AbbVie Presents Positive Results from Phase 3 SELECT-AXIS 2 Trials of Upadacitinib …

Axial spondyloarthritis is a chronic inflammatory disease that affects the spine, causing back pain, limited mobility, and structural damage.6 It …
Source: back pain